| Publications | PubMed=7803265; DOI=10.1111/j.1365-2141.1994.tb05012.x
Yamada Y., Fujita M., Suzuki H., Atogami S., Sohda H., Murata K., Tsukasaki K., Momita S., Kohno T., Maeda T., Joh T., Kamihira S., Shiku H., Tomonaga M.
Established IL-2-dependent double-negative (CD4- CD8-) TCR alpha beta/CD3+ ATL cells: induction of CD4 expression.
Br. J. Haematol. 88:234-241(1994) PubMed=9172809; DOI=10.3109/10428199609093442
Yamada Y., Ohmoto Y., Hata T., Yamamura M., Murata K., Tsukasaki K., Kohno T., Chen Y.-X., Kamihira S., Tomonaga M.
Features of the cytokines secreted by adult T cell leukemia (ATL) cells.
Leuk. Lymphoma 21:443-447(1996) PubMed=9596675; DOI=10.1182/blood.V91.11.4265
Yamada Y., Sugawara K., Hata T., Tsuruta K., Moriuchi R., Maeda T., Atogami S., Murata K., Fujimoto K., Kohno T., Tsukasaki K., Tomonaga M., Hirakata Y.-i., Kamihira S.
Interleukin-15 (IL-15) can replace the IL-2 signal in IL-2-dependent adult T-cell leukemia (ATL) cell lines: expression of IL-15 receptor alpha on ATL cells.
Blood 91:4265-4272(1998) PubMed=10190897; DOI=10.1084/jem.189.7.1063; PMCID=PMC2193006
Maeda T., Yamada Y., Moriuchi R., Sugahara K., Tsuruda K., Joh T., Atogami S., Tsukasaki K., Tomonaga M., Kamihira S.
Fas gene mutation in the progression of adult T cell leukemia.
J. Exp. Med. 189:1063-1071(1999) PubMed=10863977; DOI=10.1034/j.1600-0609.2000.90110.x
Yamada Y., Sugahara K., Tsuruda K., Nohda K., Mori N., Hata T., Maeda T., Hayashibara T., Joh T., Honda M., Tawara M., Tomonaga M., Miyazaki Y., Kamihira S.
Lactacystin activates FLICE (caspase 8) protease and induces apoptosis in Fas-resistant adult T-cell leukemia cell lines.
Eur. J. Haematol. 64:315-322(2000) PubMed=12207908; DOI=10.1016/S0006-291X(02)02039-9
Maeda T., Nakayama S., Yamada Y., Sugahara K., Isomoto H., Tawara M., Yamasaki R., Onimaru Y., Matsushita T., Ohzono Y., Kamihira S.
The conformational alteration of the mutated extracellular domain of Fas in an adult T cell leukemia cell line.
Biochem. Biophys. Res. Commun. 296:1251-1256(2002) PubMed=15638862; DOI=10.1111/j.1365-2141.2004.05289.x
Hasegawa H., Yamada Y., Harasawa H., Tsuji T., Murata K., Sugahara K., Tsuruda K., Ikeda S., Imaizumi Y., Tomonaga M., Masuda M., Takasu N., Kamihira S.
Sensitivity of adult T-cell leukaemia lymphoma cells to tumour necrosis factor-related apoptosis-inducing ligand.
Br. J. Haematol. 128:253-265(2005) PubMed=19220422; DOI=10.1111/j.1600-0609.2009.01211.x
Kamihira S., Terada C., Sasaki D., Yanagihara K., Tsukasaki K., Hasegawa H., Yamada Y.
Aberrant p53 protein expression and function in a panel of hematopoietic cell lines with different p53 mutations.
Eur. J. Haematol. 82:301-307(2009) PubMed=19710698; DOI=10.1038/leu.2009.171
Hasegawa H., Yamada Y., Iha H., Tsukasaki K., Nagai K., Atogami S., Sugahara K., Tsuruda K., Ishizaki A., Kamihira S.
Activation of p53 by Nutlin-3a, an antagonist of MDM2, induces apoptosis and cellular senescence in adult T-cell leukemia cells.
Leukemia 23:2090-2101(2009) PubMed=27193821; DOI=10.1111/cas.12971; PMCID=PMC4982578
Hasegawa H., Bissonnette R.P., Gillings M., Sasaki D., Taniguchi H., Kitanosono H., Tsuruda K., Kosai K., Uno N., Morinaga Y., Imaizumi Y., Miyazaki Y., Yanagihara K.
Induction of apoptosis by HBI-8000 in adult T-cell leukemia/lymphoma is associated with activation of Bim and NLRP3.
Cancer Sci. 107:1124-1133(2016) |
|---|
